Table 2. Overview of respiratory support and concomitant inotropic medications during levosimendan administration.

Patients (n=15)		n (%)
Respiratory support therapy
	Mechanically ventilated	10 (66.7%)
	High flow oxygen	5 (33.3%)
Concomitant inotropes
	Epinephrine + milrinone	10 (66.6%)
	Epinephrine + milrinone + dopamine	2 (13.3%)
	Epinephrine + milrinone + norepinephrine	3 (20%)